Dustin Baker1, Brandon Sherrod, Gerald McGwin, Brent Ponce, Shawn Gilbert. 1. From the Department of Surgery, Division of Orthopaedic Surgery (Mr. Baker, Mr. Sherrod, Dr. Ponce, and Dr. Gilbert) and the Department of Epidemiology (Dr. McGwin), the University of Alabama at Birmingham, and the Children's Hospital of Alabama (Dr. Gilbert), Birmingham, AL.
Abstract
INTRODUCTION: The risk of morbidity associated with venous thromboembolism (VTE) after pediatric orthopaedic surgery remains unclear despite increased use of thromboprophylaxis measures. METHODS: The American College of Surgeons National Surgical Quality Improvement Program, Pediatric database was queried for patients undergoing an orthopaedic surgical procedure between 2012 and 2013. Upper extremity and skin/subcutaneous surgeries were excluded. Associations between VTE and procedure, demographics, comorbidities, preoperative laboratory values, and 30-day postoperative outcomes were evaluated. RESULTS: Of 14,776 cases, 15 patients (0.10%) experienced postoperative VTE. Deep vein thrombosis (DVT) occurred in 13 patients (0.09%), and pulmonary embolism developed in 2 patients (0.01%). The procedure with the highest VTE rate was surgery for infection (1.2%). Patient factors associated with the development of VTE included hyponatremia (P = 0.003), abnormal partial thromboplastin time (P = 0.046), elevated aspartate transaminase level (P = 0.004), and gastrointestinal (P = 0.011), renal (P = 0.016), and hematologic (P = 0.019) disorders. Nearly half (46.2%) of DVTs occurred postdischarge. Complications associated with VTE included prolonged hospitalization (P < 0.001), pneumonia (P < 0.001), unplanned intubation (P = 0.003), urinary tract infection (P = 0.003), and central line-associated bloodstream infection (P < 0.001). Most of the postoperative complications (66.7%) occurred before VTE diagnosis, and no patients with VTE died. CONCLUSION: In the absence of specified risk factors, thromboprophylaxis may be unnecessary for this population.
INTRODUCTION: The risk of morbidity associated with venous thromboembolism (VTE) after pediatric orthopaedic surgery remains unclear despite increased use of thromboprophylaxis measures. METHODS: The American College of Surgeons National Surgical Quality Improvement Program, Pediatric database was queried for patients undergoing an orthopaedic surgical procedure between 2012 and 2013. Upper extremity and skin/subcutaneous surgeries were excluded. Associations between VTE and procedure, demographics, comorbidities, preoperative laboratory values, and 30-day postoperative outcomes were evaluated. RESULTS: Of 14,776 cases, 15 patients (0.10%) experienced postoperative VTE. Deep vein thrombosis (DVT) occurred in 13 patients (0.09%), and pulmonary embolism developed in 2 patients (0.01%). The procedure with the highest VTE rate was surgery for infection (1.2%). Patient factors associated with the development of VTE included hyponatremia (P = 0.003), abnormal partial thromboplastin time (P = 0.046), elevated aspartate transaminase level (P = 0.004), and gastrointestinal (P = 0.011), renal (P = 0.016), and hematologic (P = 0.019) disorders. Nearly half (46.2%) of DVTs occurred postdischarge. Complications associated with VTE included prolonged hospitalization (P < 0.001), pneumonia (P < 0.001), unplanned intubation (P = 0.003), urinary tract infection (P = 0.003), and central line-associated bloodstream infection (P < 0.001). Most of the postoperative complications (66.7%) occurred before VTE diagnosis, and no patients with VTE died. CONCLUSION: In the absence of specified risk factors, thromboprophylaxis may be unnecessary for this population.
Authors: Edward Vincent S Faustino; Sheila Hanson; Philip C Spinella; Marisa Tucci; Sarah H O'Brien; Antonio Rodriguez Nunez; Michael Yung; Edward Truemper; Li Qin; Simon Li; Kimberly Marohn; Adrienne G Randolph Journal: Crit Care Med Date: 2014-05 Impact factor: 7.598
Authors: Patricia Massicotte; Jim A Julian; Michael Gent; Karen Shields; Velma Marzinotto; Barbara Szechtman; Maureen Andrew Journal: Thromb Res Date: 2003-01-25 Impact factor: 3.944
Authors: Gaia Georgopoulos; Mark S Hotchkiss; Bryan McNair; Georgette Siparsky; Patrick M Carry; Nancy H Miller Journal: J Pediatr Orthop Date: 2016-01 Impact factor: 2.324
Authors: Christopher J Goodenough; Cassie A Hartline; Shuyan Wei; Joseph K Moffitt; Alfredo Cepeda; Phuong D Nguyen; Matthew R Greives Journal: Eplasty Date: 2022-09-07
Authors: Brandon A Sherrod; Samuel G McClugage; Vincent E Mortellaro; Inmaculada B Aban; Brandon G Rocque Journal: J Pediatr Surg Date: 2018-10-10 Impact factor: 2.545